Flumedroxone
Clinical data | |
---|---|
Other names | 17α-Hydroxy-6α-(trifluoromethyl)pregn-4-ene-3,20-dione; 6α-Trifluoromethyl-17α-hydroxyprogesterone |
Identifiers | |
IUPAC name
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C22H29F3O3 |
Molar mass | 398.466 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
Flumedroxone is a steroidal progestogen of the 17α-hydroxyprogesterone group that was never marketed.[1] The C17α acetate ester of flumedroxone, flumedroxone acetate, has been marketed as an antimigraine drug.[1]
References
- 1 2 J Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 560–. ISBN 978-1-4757-2085-3.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.